中文名称 | (S)-2-(6-(4-氯苯基)-1-甲基-4H-苯并[c]异恶唑并[4,5-e]氮杂环庚烷-4-基)乙酰胺 |
---|---|
英文名称 | Pelabresib (Synonyms: CPI-0610) |
CAS号 | 1380087-89-7 |
分子式 | C20H16ClN3O2 |
分子量 | 365.81 |
MDL | MFCD28144505 |
外观 | White to off-white powder |
储存条件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Pelabresib (CPI-0610) is a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor with an IC50 of 39 nM for BRD4-BD1 in TR-FRET assay and currently undergoing human clinical trials for hematological malignancies. CPI-0610 inhibits the expression of Nuclear receptor binding SET domain protein 3 (NSD3) target genes.
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft